BGLC — BioNexus Gene Lab Corp Common stock
NASDAQ · Basic Materials · Specialty Chemicals
$1.47
-$0.02 (-1.34%)
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ. It is led by Su-Leng Tan, based in Menara UOA Bangsar, Kuala Lumpur, Malaysia, 59000, with about 19 employees. BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Latest reported BGLC revenue for 2025-09-30 was $2.5M. Net income was -$709.0K. Revenue was up 12.5% from 2025-06-30 to 2025-09-30. BGLC currently screens at market cap $6.1M.
Use this BGLC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BGLC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BGLC SEC filings page. Lician reads the product cache first so this HTML stays unique to BioNexus Gene Lab Corp Common stock even when a live quote feed is slow.
About BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
BGLC Key Statistics
Market Cap
$6.09M
Previous Close
$1.55
Day Range
$1.55 – $1.55
P/B Ratio
0.74
EPS
-$0.09
Revenue
$9.51M
Net Income
$1.60M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-2.7%
Profit Margin
16.8%
Employees
19
BGLC Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $9.51M | $9.77M | $10.93M | $13.36M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $1.60M | $2.63M | -$355.97K | $751.57K |
| EPS (Diluted) | -$0.09 | -$0.17 | $0.00 | $0.00 |
Total Assets
$10.43M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$0.00
Operating Cash Flow
-$2.23M
Free Cash Flow
$0.00
BioNexus Gene Lab Corp Common stock Company Information
- CEO, President, Secretary & Director
- Su-Leng Tan
- Headquarters
- Menara UOA Bangsar, Kuala Lumpur, Malaysia, 59000
- Website
- www.bionexusgenelab.com
- Phone
- 60 1 307 241 6898
- IPO / Founded
- 2020-09-16
- Sector
- Basic Materials
- Industry
- Specialty Chemicals